Literature DB >> 12923939

Reconstructive procedure to repair chronic injuries to the collateral ligament of metacarpophalangeal joints of the hand.

Yoshinori Oka1, Hiroki Harayama, Masayoshi Ikeda.   

Abstract

We have devised a reconstructive procedure to repair chronic injuries to the collateral ligament of metacarpophalangeal (MCP) joints. It comprises palmaris longus tendon grafting into a bone tunnel and suturing onto the base of the residual ligament without involving fixation of the tendon graft stump. Thirteen patients were treated for injured MCP joints: thumb/ulnar, ten cases; thumb/radial, two; and middle finger/radial, one. All patients had pain and instability of average 41 degrees in the affected MCP joints. The patients were followed at an average period of five years and nine months. Pain and joint instability disappeared in all patients. The mean MCP joint range of motion (ROM) was 1 degrees on extension and 58 degrees on flexion. The tip pinch strength averaged 4.8 kg. The gratifying results obtained using this method are attributed to the fact that optimal tension of the ligament and satisfactory ROM can be achieved during the course of rehabilitation.

Entities:  

Mesh:

Year:  2003        PMID: 12923939     DOI: 10.1142/s021881040300156x

Source DB:  PubMed          Journal:  Hand Surg        ISSN: 0218-8104


  3 in total

1.  Long-Term Outcomes of Primary Repair of Chronic Thumb Ulnar Collateral Ligament Injuries.

Authors:  Thomas Christensen; Shumaila Sarfani; Alexander Y Shin; Sanjeev Kakar
Journal:  Hand (N Y)       Date:  2016-03-14

2.  Early Return to Play With Thumb Spica Gauntlet Casting for Ulnar Collateral Ligament Injuries Complicated by Adjacent Joint Dislocations in Collegiate Football Linemen.

Authors:  Derek T Bernstein; Patrick C McCulloch; Leland A Winston; Shari R Liberman
Journal:  Hand (N Y)       Date:  2018-07-17

Review 3.  Sports-related wrist and hand injuries: a review.

Authors:  Daniel M Avery; Craig M Rodner; Cory M Edgar
Journal:  J Orthop Surg Res       Date:  2016-09-16       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.